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L-type bovine spongiform encephalopathy (L-BSE) is an atypical form of BSE that is transmissible to cattle and several
lines of prion protein (PrP) transgenic mice, but not to wild-type mice. In this study, we examined the transmissibility of
sheep-passaged L-BSE prions to wild-type mice. Disease-associated prion protein (PrPSc) was detected in the brain and/
or lymphoid tissues during the lifespan of mice that were asymptomatic subclinical carriers, indicating that wild-type
mice were susceptible to sheep-passaged L-BSE. The morphological characteristics of the PrPSc of sheep-passaged
L-BSE included florid plaques that were distributed mainly in the cerebral cortex and hippocampus of subsequent
passaged mice. The PrPSc glycoform profiles of wild-type mice infected with sheep-passaged L-BSE were similar to
those of the original isolate. The data indicate that sheep-passaged L-BSE has an altered host range and acquired
transmissibility to wild-type mice.Introduction
Bovine spongiform encephalopathy (BSE) was originally
thought to be caused by a single prion strain, based on
analysis of its biological and biochemical characteristics.
However, since 2003, different pathological and molecu-
lar phenotypes of BSE (known as atypical BSE) have
been reported in approximately 90 cases worldwide,
mainly in aged cattle. Currently, atypical BSE is classified
into two groups depending on whether the proteinase K
(PK)-resistant abnormal, disease-associated form of the
prion protein (PrPSc) has higher (H-BSE) or lower (L-
BSE) molecular mass than that of classical (C-) BSE [1].
The origins of atypical BSE remain obscure; it is unlike
C-BSE, but it is possibly a sporadic form of BSE [2].
Experimentally, L-BSE prions have shown transmissibil-
ity by intracerebral challenge to cattle [3-6]; bovinized
[7-10], ovinized [7,10,11], and humanized prion protein
(PrP) transgenic mice [12]; Syrian hamsters [13,14], and
non-human primates [15] with a shorter incubation period
than C-BSE. In contrast, L-BSE was transmitted to sheep
with a longer incubation period than C-BSE [10,16]. L-
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creativecommons.org/publicdomain/zero/1.0/spongiform encephalopathy (BASE), was transmissible to
wild-type mice after subsequent passages, with an altered
C-BSE-like phenotype [17]. In this study, we examine the
biological and biochemical characteristics of ARQ/ARQ
sheep-passaged L-BSE (L-BSE/sheep) to evaluate any al-
teration or consistency in the biological phenotypes during
inter-species transmission.Materials and methods
Experimental design
All the experiments involving animals were performed
with the approval of the Animal Ethics Committee and
the Animal Care and Use Committee of the National
Institute of Animal Health (approval ID: 10–005 and
11–008). Fifteen 3-week-old outbred ICR (CD-1) mice
(Japan SLC Inc., Shizuoka, Japan) were inoculated in-
tracerebrally with 20 μL of 10% brain homogenates of
Japanese L-BSE [18] passaged in an ARQ/ARQ Cheviot
ewe [16]. Inoculated mice were maintained in an ani-
mal biological containment level 3 facility under identi-
cal environmental conditions (21–22 °C, 50–60% relative
humidity) and examined daily for neurological signs of the
disease.ticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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At necropsy, the left hemisphere and selected tissues
including the lymphoid organs were removed and fixed
in 10% buffered formalin containing 10% methanol.
Formalin-fixed tissues were immersed in 98% formic
acid for 60 min to reduce the infectivity, embedded in
paraffin, and sectioned for histological evaluation by
staining with hematoxylin and eosin (HE), and using
PrPSc immunohistochemistry (IHC). Selected sections
were stained with phenol Congo red and examined
under a polarizing microscope, and the presence of
amyloid was confirmed by observation of its character-
istic dichroism [19].
PrPSc immunohistochemistry
After appropriate epitope retrieval with either hydrate
autoclaving or a combination of enzymatic and chemical
treatment, IHC was carried out using the monoclonal
antibodies (mAbs) 2G11, 12F10, or SAF84 (SPI-Bio,
Montigny le Bretonneux, France) followed by an anti-
mouse, universal horseradish peroxidase (HRP)-conju-
gated polymer (Nichirei Histofine Simple Stain MAX-PO
(M); Nichirei Biosciences Inc., Tokyo, Japan) as the sec-
ondary antibody, and visualized with 3,3′-diaminoben-
zedine tetrachloride as the chromogen, as previously
described [20]. Finally, the sections were lightly coun-
terstained with Mayer’s hematoxylin.
Western Blotting (WB)
The right hemisphere and spleen were removed and
stored at −80 °C until use. The tissues (200 ± 10 mg)
were homogenized at 20% concentration (w/v) in a buf-
fer containing 100 mM NaCl and 50 mM Tris–HCl
(pH 7.6). The homogenates (250 μL) were mixed with
an equal volume of detergent buffer containing 4% (w/
v) Zwittergent 3–14 (EMD Millipore, Billerica, MA,
USA), 1% (w/v) Sarkosyl, 100 mM NaCl, and 50 mM
Tris–HCl (pH 7.6), and treated with 6.25 μL of 40 mg/
mL collagenase. The sample was then digested with
40 μg/mL proteinase K (PK; Roche Diagnostics, Basel,
Switzerland) and the digestion was terminated using
2 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydro-
chloride (Pefabloc; Roche Diagnostics). After PK treat-
ment, the samples were mixed with a 2-butanol: methanol
mixture (5:1) and centrifuged at 20000 × g for 10 min. The
pellets were mixed with a gel-loading buffer containing 2%
sodium dodecyl sulfate, boiled for 5 min before electro-
phoresis, and loaded onto a 12% polyacrylamide gel. The
separated proteins were transferred onto an Immobilon-P
polyvinylidene fluoride membrane (EMD Millipore). The
blotted membranes were incubated with the mAbs SAF84
and T2 [21] followed by incubation with HRP-conjugated
anti-mouse IgG (Jackson ImmunoResearch, West Grove,
PA, USA). Signals were developed using a chemiluminescentsubstrate (SuperSignal; Pierce Biotechnology, Rockford, IL,
USA). Blots were imaged with a FluorChem system (Alpha
Innotech, San Leandro, CA, USA) and analyzed using
ImageReader software (AlphaEaseFC; Alpha Innotech)
after background subtraction.
To compare the molecular features of PrPSc in wild-type
mice inoculated with L-BSE/sheep, the brains of wild-type
mice [22,23], cattle [4,9], or sheep [16] inoculated intrace-
rebrally with C-BSE or L-BSE from cattle (L-BSE/cattle),
were also examined.
Characterization of monoclonal antibodies
The mAbs 2G11, SAF84, and T2 were found to react
with bovine, ovine, and mouse PrP; the mAb 12F10 re-
acts with both bovine and ovine, but not mouse PrP.
Back passage of L-BSE/sheep in wild-type to bovinized
PrP (TgBoPrP) mice
To compare the phenotypic features of L-BSE inoculum
before and after passage in sheep, reverse transmission
to bovinized PrP expressing transgenic (TgBoPrP) mice
was carried out to examine whether the L-BSE/sheep
would maintain its specific strain properties in bovids.
TgBoPrP mice were kindly provided by Dr Prusiner [24].
The susceptibility of TgBoPrP mice to L-BSE has been
confirmed previously [21].
Statistical analysis
Incubation periods expressed as mean ± standard devi-
ation of the mean (SD) and signal intensities of PK-
resistant PrPSc bands were analyzed using Instat3 software
(GraphPad Software; La Jolla, CA, USA) and ImageReader
software (AlphaEaseFC; Alpha Innotech) after background
subtraction, respectively; p values <0.05 were considered
statistically significant.
Results
First and second passage of L-BSE/sheep to wild-type mice
The first-passaged mice with L-BSE/sheep showed no
clinical signs of the disease and were sacrificed at the
end of their lives, or at an earlier stage of deterioration
in accordance with welfare concerns relating to animal
experiments, during the period between 172 and 1012 days
post-inoculation (dpi) (Table 1). A PrPSc signal was de-
tected by WB, IHC, or both techniques in the brain from
1 case at 710 dpi, and in lymphoid tissues (including
spleen, lymph nodes, tonsils, and Peyer’s patches) from 9
of 15 mice after 200 dpi after the first passage. Positive
IHC results in a mouse were typically composed of sparse
granular deposits in some areas of the brain such as
the vestibular nucleus or dorsal motor nucleus of the
vagal nerve, midbrain tegmentum, hypothalamus, medial
preoptic nucleus, and habenular nucleus (Figure 1). In
addition, intense PrPSc immunolabeling in the follicles of
Table 1 Transmission of L-BSE isolates to micea





Proportion of PrPSc micec
Brain Spleen
ICR [14] L-BSE/cattle [18] Brain 1 651 ± 153 322–953 0/35 0/35
ICR L-BSE/cattle passaged in ICR mice Brain 2 666 ± 198 386–937 0/10 0/10
C57BL/6d L-BSE/cattle [18] Brain 1 713 ± 42 673–757 0/5 0/5
ICR L-BSE/sheep [16] Brain 1 569 ± 262 172–1012 1/15 9/15
ICR L-BSE/sheep passaged in ICR mice Spleen 2 691 ± 61 639–765 6/6 6/6
TgBoPrP L-BSE/cattle [18] Brain 1 195 ± 6 187-211 18/18 0/18
TgBoPrP L-BSE/cattle passaged in TgBoPrP mice Brain 2 152 ± 2 148-155 24/24 0/24
TgBoPrP L-BSE/sheep [16] Brain 1 249 ± 28 234-298 5/5 0/5
TgBoPrP L-BSE/sheep passaged in TgBoPrP mice Brain 2 269 ± 17 248-305 13/13 0/13
aTgBoPrP, bovine PrP expressing transgenic; L-BSE, L-type bovine spongiform encephalopathy; PrPSc, disease-associated prion protein.
bmean ± standard deviation.
cNumber of PrPSc positive tissue samples per number of examined tissue samples. Results from either western blot, immunohistochemistry, or both.
dUnpublished data from our laboratory.
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(Figure 1D). The mAbs 2G11 and SAF84 produced posi-
tive results in the sections, but mAb 12F10 was negative.
However, transmission of the original isolate of L-BSE/
cattle into wild-type mice was inefficient, and resulted in
no clinical signs of the disease at the end of the lifespan,
and an absence of positive signals in the brains and
lymphoid tissues by WB and IHC analyses (Table 1).A 
C 
Figure 1 Immunolabeled PrPSc accumulation in the brain and lymph
passage. PrPSc accumulated in the brain of the medial preoptic nucleus (A
follicular dendritic cells within the secondary follicle of renal lymph node (D
labeling with mAb SAF84 and hematoxylin counterstain. Scale bar = 25 μmThe inoculum prepared from PrPSc-positive spleens of
mice was used for subsequent second passages in ICR
mice (Table 1). The long survival period of 691 ± 61 days
(n = 6) was statistically unchanged on second passage,
without any clinical signs and a 100% transmission rate.
Histopathological examination showed prominent florid
and non-florid plaques with large confluent vacuoles in
the cerebral cortex and hippocampus of all inoculatedD 
B 
node of ICR mice infected with sheep-passaged L-BSE, at first
), habenular nucleus (B), and midbrain tegmentum (C), and in the
) of a mouse killed at 710 days post-inoculation. Immunohistochemical
.
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were generally stained pale basophilic or amphophilic
with HE and positively with Congo red under polarized
light. A few non-florid plaques were also detected in the
thalamus, midbrain tegmentum, and vestibular nucleus.
In addition, coarse granular PrPSc and PrPSc aggregates
accumulated in the septal nuclei, diagonal band of
Broca, hippocampus, hypothalamus, and several limited
regions of the cerebral cortex, the olfactory bulb, and
the olfactory tract of the frontal cortex (Figure 2B).
However, some variation in the intensity of immunola-
beling was observed throughout the brain. In addition to
the brains of these mice, positive PrPSc immunolabeling
was detected in the retina, but not in the spinal cords,
trigeminal and dorsal root ganglia, and muscle bundles
of skeletal muscle fibers. The pathological results re-
vealed striking differences between first- and second-
passaged mice; however the findings from the immuno-
labeling reactions conducted using the mAbs SAF84,A
B
1 2 3
Figure 2 Neuroanatomical distribution and morphological patterns of P
passaged L-BSE, at second passage. A The 5 coronal brain sections are as fo
4. midbrain, and 5. medulla with cerebellum. PrP-plaque deposits are abundan
Granular and aggregated PrPSc accumulated in the septal nuclei (2), hypothalam
PrPSc immunohistochemical analysis with mAb SAF84 revealed plentiful florid p
hippocampus. Insets show high-magnification images of a florid plaque. Scale2G11, and 12F10 for the second-passaged mice were
similar to those for the first-passaged mice.
Molecular features of PK-resistant PrPSc in wild-type mice
affected with L-BSE/sheep
Conventional WB features of PK-resistant PrPSc, such as
the electrophoretic mobility and the relative proportions
and pattern of the glycoforms obtained using the mAbs
T2 and SAF84, were similar between the first and the
second passage in the brain and spleen of wild-type mice
inoculated with L-BSE/sheep (Figure 3A). The molecular
mass of the unglycosylated form was ~18 kDa in cattle,
sheep, and wild-type mice affected with L-BSE. Interest-
ingly, the three bands in samples from wild-type mice
represented higher molecular mass forms compared with
those of cattle and sheep affected with L-BSE (Figure 3B).
Of note, the PrPSc glycoprofile of L-BSE/sheep-affected
wild-type mice resembled those of L-BSE-affected cattle4 5
rPSc accumulation in the brain of ICR mice infected with sheep-
llows: 1. frontal cortex, 2. septal level, 3. hippocampus and thalamic level,
t throughout the cerebral gray matter (1 to 4) and hippocampus (3 and 4).
us (3), and temporal cortex (4). Scale bar = 1 mm. B Histopathology and
laques accompanied by granular and aggregated PrPSc deposits in the
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A
Figure 3 Western blot analysis of proteinase-K resistant PrPSc
analyzed using monoclonal antibody T2. A PrPSc in the brain (Br)
and spleen (Sp) of wild-type mice inoculated with sheep-passaged L-BSE
at the first and second passage. All samples were digested with
50 μg/mL of proteinase-K at 37 °C for 1 h. Lanes from left to right were
loaded with 0.625, 5, 0.0125, and 0.36 mg tissue equivalent, respectively.
The molecular markers are shown on the left (kDa). B PrPSc in the brain
of C-BSE- and L-BSE-affected cattle and mice. Lane 1: C-BSE affected
cattle, Lane 2: C-BSE affected ICR mouse, Lane 3: L-BSE affected cattle,
Lane 4: L-BSE affected sheep, and Lane 5: sheep-passaged L-BSE
affected ICR mouse at second passage. Lanes 1, 3, and 4, and Lanes 2
and 5 were loaded with 1.25 and 0.125 mg tissue equivalent,
respectively. C Quantification of the relative amounts of the
di-, mono-, and unglycosylated forms of PrPSc from the brain. The
column numbers are as listed in (B). Bar diagram indicates the
diglycosylated form (black), monoglycosylated form (gray), and
unglycosylated form (white). Data are expressed as mean ± standard
deviation of triplicate experiments.
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cattle and wild-type mice (Figure 3C).
Reverse transmission of L-BSE/sheep to TgBoPrP mice
Transmission of L-BSE/cattle to TgBoPrP mice resulted in
a mean incubation period of 195 ± 6 (n = 18) and 152 ±
2 days (n = 24) at primary and secondary passage, respect-
ively. In contrast, the mean incubation period of L-BSE/
sheep to TgBoPrP mice was 249 ± 28 (n = 5) and 269 ±
17 days (n = 13) at primary and secondary passage, re-
spectively, which indicated a significantly longer incuba-
tion period compared to L-BSE/cattle, the original isolate
(Table 1). However, pathological changes including lesion
profiles and distribution patterns or types of PrPSc, and
molecular features of PK-resistant PrPSc in the brains of
TgBoPrP mice inoculated with L-BSE/sheep were identical
to those in mice inoculated with L-BSE/cattle (Figure 4).
In addition, PK-resistant PrPSc in TgBoPrP mice inoculated
with either L-BSE/sheep or L-BSE/cattle showed similar
biochemical profiles to L-BSE/cattle, the original isolate.
No transmissibility of L-BSE/cattle to wild-type mice
Wild-type mice inoculated with L-BSE/cattle did not de-
velop prion diseases. In addition, a second “blind” pas-
sage transmission of brain homogenates from L-BSE/
cattle-inoculated ICR mice to normal ICR mice (n = 10)
showed a lack of any evidence of transmission during
their lifespan by both WB and IHC tests (Table 1).
Discussion
A transmission study performed on experimental animals
is a useful approach for the isolation and characterization







1 2 3 1 2 3 
Figure 4 Western blot analysis of proteinase-K resistant L-BSE
PrPSc in TgBoPrP mice before and after passage in sheep. The brain
samples of TgBoPrP mice inoculated intracerebrally with either L-BSE/
cattle or L-BSE/sheep were analyzed. PrPSc in the twice-passaged mice
was detected with mAb T2. The numbers indicate three different mice.
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type mice across a species barrier during their lifespans, in
the absence of clinical signs of the disease. According
to the protein-only hypothesis, PrPSc is the principal
component of the infectious agent and the conform-
ational differences in PrPSc determine the strain pheno-
type [25]. The PrPSc conformational change at the
molecular level is believed to be essential during inter-
species transmission. The conformational transition of
mouse PrPSc might occur during adaptation in the
sheep-to-wild-type mice transmission of L-BSE prions
[26]. Since this mechanism would be limited to devel-
oping heterologous PrPSc aggregation before the mice
reach the end of their lifespan at first passage, mouse
PrPSc would fit the given environment and propagate in
mouse brains with a 100% attack rate of the infection
at second passage [27]. Interestingly, PrPSc propagated
substantially in the lymphoid tissues of more than half
of the affected mice, and was detected there as early as
200 dpi. This was not the case in the brain, except for
only 1 case before 710 dpi, suggesting that L-BSE/sheep
showed apparent lymphotropism in wild-type mice at
an early stage of infection, from the first passage.
Propagation of PrPSc in lymphoid tissues has been re-
ported in ovine PrP transgenic mice carrying the ARQ
allele (TgOvPrP) that are affected by L-BSE/sheep [10],
whereas lymphoid PrPSc accumulation has not been de-
tected in cattle [5,28] or sheep [16] affected by L-BSE and
wild-type mice affected with C-BSE [29]. In addition, the
presence of clear lymphotropism in animals with a sub-
clinical status has been reported in transgenic mouse
models affected by BSE, chronic wasting disease, or Sc237
[30]. Thus, some prion strains exhibit a much greater pref-
erence for propagating in lymphoid tissue than in nervous
tissue, and at an early stage of infection via cross-species
transmission, notwithstanding intracerebral exposure
[30,31]. Consequently, the accumulation of PrPSc in
lymphoid tissues does not necessarily result in neuroinva-
sion [31]. In the experiment involving secondary transmis-
sion using spleen homogenates from primary-passaged
mice, the disease was found to progress to the subclinical
stage of infection only after 600 days, although conspicu-
ous PrPSc deposits accumulated in the brain. This result
indicates that L-BSE/sheep may not have pathogenicity
and virulence towards wild-type mice. The discrimin-
ation and typing of prion strains are dependent on bio-
logical characteristics that include clinical signs,
incubation times, histopathological vacuolar lesion pro-
files, PrPSc deposition patterns in the brain, and the
biochemical features of PrPSc over several mouse pas-
sages [32,33].
In the results of WB tests, a strain-specific molecular
signature such as the glycoform pattern was conserved
in the transmitted wild-type mice. The occurrence ofsize shifts in PK-digested PrPSc has been reported in
cross-species transmission of sporadic Creutzfeldt-Jakob
disease (CJD) to humanized transgenic mice [34], variant
CJD to wild-type mice [35], and hamster Sc237 to wild-
type mice [36]. The transmission of L-BSE/sheep did not
alter the glycoprofile of PrPSc, but gained the transmissi-
bility to wild-type mice. Although the key event that de-
termines the shift in the size of PK-resistant PrPSc remains
unknown, it seems likely that the molecular characteristics
may be influenced by the host-environment factors rather
than the nature of the prion strain. The specific strain fea-
tures of L-BSE observed in TgBoPrP mice affected with L-
BSE/cattle [22,37] or L-BSE/sheep were consistent after
the passage transmission in sheep.
To the best of our knowledge, the transmission of L-
BSE/cattle to wild-type mice has only been reported in
one study, and even in this case the L-BSE prions were
converted to a C-BSE-like prion using serial passages, and
had indistinguishable phenotypic traits compared with
mouse-passaged C-BSE [17]. A phenotypic change during
the transmission of prions is a common phenomenon
across a species barrier [33,38,39]. However, the reasons
for the discrepancy between this study here and another,
suggesting that BASE prion converts into C-BSE-like phe-
notypes during interspecies transmission in wild-type mice
[17] are unknown. Several possible reasons are concisely
considered: (1) cross contamination may occur during the
inoculation procedure, (2) undetectable levels of C-BSE
agent by WB analysis emerge in the brain of mice chal-
lenged with BASE at the first passage, thereafter inocu-
lated mice develop the disease in subsequent passages
[29], (3) L-BSE could generate at least 2 types of prions in
wild-type mice: one showing L-BSE phenotypic properties
and the other producing C-BSE-like signatures, (4) differ-
ences of unidentified prion-related host factors between
outbred (ICR) and inbred (C57BL/6, SJL, or RIII) mice
may have influenced the emergence of C-BSE-like prions
during the cross-species transmission, and (5) differences
of experimental procedures including prepared inocula
and/or challenge routes of the infection may have influ-
enced the propagation and/or generation of PrPSc in the
brain. The first two possibilities were completely ruled
out by the authors [17]. The last possibility, is that
mice were inoculated by a combination of intracere-
bral and intraperitoneal routes with a thalamic sample
at first passage and with brain pools prepared from
C57Bl/6 or SJL mice at second passage [17], should
help address this issue [40]. No transmissibility including
lymphotropism was found on the first passage in the
Italian study. Although PrPSc was undetectable in the
brain of these mice, a faint positive signal was identified
in one RIII mouse that showed biochemical characteris-
tics of PrPSc identical to those of C-BSE-infected mice by
WB analyses.
Okada et al. Veterinary Research  (2015) 46:81 Page 7 of 8Four L-BSE isolates from Japan [18], Germany [8],
France [41], and Canada [42] were transmitted to TgBoPrP
mice and no distinctive differences were detected in their
pathological and molecular signatures [37]. These results
suggest that the Japanese L-BSE isolates (BSE/JP24) used
in this study may be identical to those from Canadian and
European L-BSE cases examined. However, further studies
regarding transmission to wild-type mice using these L-
BSE isolates is now under consideration to address the
issue that L-BSE prions from cattle are not transmitted to
wild-type mice, which is a general phenomenon for L-BSE
prions that is not restricted to the isolate used in this
study. Furthermore, reverse transmission of L-BSE/sheep
to TgBoPrP mice showed that L-BSE prions retained their
pathological and biochemical signatures after passage in
ARQ/ARQ sheep, which was in accordance with the find-
ings of a previous study [10]. However, the mean incu-
bation period of L-BSE/sheep affected TgBoPrP mice
was much longer than that of L-BSE/cattle. Although
the exact reason for the discrepancy that determines
the incubation periods remains unknown, the environ-
ment in sheep as an intermediate host may influence
the incubation periods.
Finally, the results indicate that L-BSE/sheep is trans-
missible to wild-type mice and it results in low virulence
compared with C-BSE [23]. In contrast, experimental
transmission of sheep-passaged C-BSE to bovine PrP
transgenic mice induced a shorter incubation period and
more severe neuropathological changes compared to cat-
tle C-BSE, suggesting that the pathogenic properties of
the C-BSE agent were altered during the inter-species
transmission, making it more virulent in sheep [43].
Amino acid differences between the host PrPC and the
PrPSc of inocula result in species barriers to the
cross-species transmission of prions [33]. In this con-
text, the transmission of L-BSE to wild-type mice
may be influenced by the ovine PrP amino-acid
sequence. The biochemical nature of the protein in
terms of its glycoform profile is identical in original
L-BSE, L-BSE/sheep, and inoculated mice, even after
the subsequent passage. Here, we have generated
mouse-passaged L-BSE prions, which have the similar
biochemical characteristics as the original cattle L-BSE.
Therefore, this wild-type mouse model may be a useful
experimental tool for elucidating BSE prion strains. The
transmission experiment reported here shows that the
host range of L-BSE prions can be extended by inter-
species transmission. Further experimental transmission
of L-BSE/sheep along with L-BSE into humanized PrP
mice will be necessary to evaluate the potential risk for
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